Acta Scientific Cancer Biology (ASCB) (ISSN: 2582-4473)

Clinical Review Volume 7 Issue 1

Gyration and Curlicue-Sézary Syndrome

Anubha Bajaj*

Consultant, Histopathologist, A.B. Diagnostics, India

*Corresponding Author: Anubha Bajaj, Consultant, Histopathologist, A.B. Diagnostics, India.

Received: December 13, 2022; Published: February 24, 2023

Erythrodermic cutaneous T cell lymphoma (CTCL) is constituted of primary cutaneous lymphomas which manifest erythroderma such as Sézary syndrome and erythrodermic mycosis fungoides.

Sézary syndrome is defined as a leukemic variant of cutaneous T cell lymphoma (CTCL) demonstrating erythroderma, generalized lymphadenopathy and clonal T cell proliferation. Clonal, neoplastic T cells are imbued with cerebriform nuclei (Sézary cells) and may disseminate within cutaneous surfaces, regional lymph nodes and peripheral blood.

References

  1. Roccuzzo G., et al. “Sézary Syndrome: Different Erythroderma Morphological Features with Proposal for a Clinical Score System”. Cells3 (2022): 333.
  2. Jonak C., et al. “Mycosis fungoides and Sézary syndrome”. Journal der Deutschen Dermatologischen Gesellschaft 9 (2021): 1307-1334.
  3. Vakiti A., et al. “Sézary Syndrome”. Stat Pearls International 2022, Treasure Island, Florida (20202).
  4. Snowden C., et al. “Partial remission of advanced untreated Sézary syndrome after COVID-19”. JAAD Case Report 21 (2022): 165-168.
  5. Image 1 Courtesy: Plastic surgery key.
  6. Image 2 Courtesy: Springer link.

Citation

Citation: Anubha Bajaj. “Gyration and Curlicue-Sézary Syndrome" Acta Scientific Cancer Biology 7.1 (2023): 15-19.

Copyright

Copyright: © 2022 Anubha Bajaj. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days
Impact Factor1.183

Indexed In




News and Events


Contact US